Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis

BACKGROUND AND AIM: Existing data are controversial regarding the incidence of hepatitis C (HCV)–related hepatocellular carcinoma (HCC) following directly acting antiviral (DAA) therapy. This prospective study aimed to assess incidence, and risk factorss of HCC following DAA therapy in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilany, Shimaa, Ata, Lmyaa, Gomaa, Asmaa, Sabry, Aliaa, Nada, Ali, Tharwa, El-Sayed, Badra, Gamal, Abogabal, Ashraf, Elwaraky, Mohamed, Moaz, Enas, Ezzat, Sameera, Elsharawy, Ahmed, Waked, Imam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367200/
https://www.ncbi.nlm.nih.gov/pubmed/34408991
http://dx.doi.org/10.2147/JHC.S295330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367200/
https://www.ncbi.nlm.nih.gov/pubmed/34408991
http://dx.doi.org/10.2147/JHC.S295330

Ejemplares similares